chr19-55368237-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000641.4(IL11):c.402C>A(p.Asp134Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000649 in 1,387,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000641.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL11 | NM_000641.4 | c.402C>A | p.Asp134Glu | missense_variant | 4/5 | ENST00000264563.7 | |
IL11 | NM_001267718.2 | c.165C>A | p.Asp55Glu | missense_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL11 | ENST00000264563.7 | c.402C>A | p.Asp134Glu | missense_variant | 4/5 | 1 | NM_000641.4 | P1 | |
IL11 | ENST00000585513.1 | c.402C>A | p.Asp134Glu | missense_variant | 4/5 | 1 | P1 | ||
IL11 | ENST00000590625.5 | c.165C>A | p.Asp55Glu | missense_variant | 3/4 | 2 | |||
IL11 | ENST00000587093.1 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000676 AC: 1AN: 147932Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 79482
GnomAD4 exome AF: 0.00000649 AC: 9AN: 1387604Hom.: 0 Cov.: 32 AF XY: 0.00000293 AC XY: 2AN XY: 682392
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.402C>A (p.D134E) alteration is located in exon 4 (coding exon 4) of the IL11 gene. This alteration results from a C to A substitution at nucleotide position 402, causing the aspartic acid (D) at amino acid position 134 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at